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Background: While societal acceptance for sexual and gender minority
(SGM) individuals is increasing, this group continues to face barriers to quality
healthcare. Little is known about clinicians’ experiences with SGM patients in
the oncology setting. To address this, a mixed method survey was administered
to members of the ECOG-ACRIN Cancer Research Group.
Materials and methods: We report results from the open-ended portion of
the survey. Four questions asked clinicians to describe experiences with SGM
patients, reservations in caring for them, suggestions for improvement in SGM
cancer care, and additional comments. Data were analyzed using content
analysis and the constant comparison method.
Results: The majority of respondents noted they had no or little familiarity
with SGM patients. A minority of respondents noted experience with gay and
lesbian patients, but not transgender patients; many who reported experience
with transgender patients also noted difficulty navigating the correct use of
pronouns. Many respondents also highlighted positive experiences with SGM
patients. Suggestions for improvement in SGM cancer care included providing
widespread training, attending to unique end-of-life care issues among SGM
patients, and engaging in efforts to build trust.
Conclusion: Clinicians have minimal experiences with SGM patients with
cancer but desire training. Training the entire workforce may improve trust
with, outreach efforts to, and cancer care delivery to the SGM community.
KEYWORDS

cancer, oncology, clinicians, healthcare disparities, sexual and gender minorities, LGBT
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Introduction

Group and American College of Radiology Imaging Network) and
practice medicine at diverse academic and non-academic medical
centers. The current study reports the results from the qualitative
portion of the survey.
Although other studies have examined barriers to healthcare
for SGM populations, including in the field of oncology, there are
limitations to existing research. First, many United States studies
are from the perspective of SGM individuals rather than
healthcare providers, or are combined studies with limited
responses from healthcare providers (Stover et al., 2014; Agénor
et al., 2015; Simoni et al., 2017; Burton et al., 2020). With the
exception of a recent study by Ussher et al., very few studies of
healthcare providers are as large or encompass multiple types of
healthcare providers (i.e., nurses, physicians, etc.; Carabez et al.,
2015; Bjarnadottir et al., 2019; Burton et al., 2020; Sutter et al.,
2020; Ussher et al., 2021). Finally, no studies thus far have
examined qualitative comments on provider attitudes and
behaviors to this extent. This study seeks to bridge that gap in
research by performing an in-depth analysis of all qualitative
comments from a large quantity of multiple types of
oncology providers.

Sexual and gender minority (SGM) populations include, but
are not limited to, those who identify as lesbian, gay, bisexual,
transgender, or queer (LGBTQ), as well as asexual, intersex, and/
or two-spirit; individuals with same-sex or -gender attractions or
behaviors, those with differences in sexual development, and those
who identify with non-binary constructs of sexual orientation,
gender, or sex are also included (Sexual and Gender Minority
Research Office, 2019). Roughly 4.5% of the United States
population, which amounts to over 11 million people, is estimated
to identify as LGBT, though this may not include other SGM
populations that do not identify as cisgender LGB or transgender
(Conron and Goldberg, 2020). SGM populations face a multitude
of health disparities compared to cisgender heterosexual
populations, stemming from issues including increased poverty
(Badgett et al., 2019), denial of care due to their sexual or gender
identity (Lambda Legal, 2010), fears related to discrimination
(Eckstrand and Potter, 2017; McNeill et al., 2021), and inadequate
training by healthcare professionals (Lambda Legal, 2010),
among others.
In addition to facing barriers to quality healthcare, SGM
patients have unique medical concerns in multiple areas, including
oncology (Quinn et al., 2015). Many cancers disproportionately
affect SGM patients, which is attributed to higher prevalence of
risk factors like alcohol use and obesity, reduced cancer screening,
and the aforementioned barriers to care (Institute of Medicine
Committee on Lesbian G, Bisexual, and Transgender Health
Issues and Research Gaps and Opportunities, 2011; Machalek
et al., 2012; Agénor et al., 2014; Quinn et al., 2015; Tabaac et al.,
2018; Charkhchi et al., 2019). Despite these well-described health
disparities among SGM patients, there is a deficiency of research
on SGM patient populations, evidence-based guidelines regarding
oncologic care in SGM patients, and training on SGM-related
cancer care (Quinn et al., 2015; Sutter et al., 2020).
As oncology providers play essential roles in SGM patients’
interactions with the healthcare system, examining their
knowledge and attitudes regarding SGM cancer patients may shed
light on the current state of the healthcare system and identify
specific areas for improvement regarding SGM patient care. Prior
studies by our group conducted among oncologists at National
Cancer Institute (NCI)-designated cancer centers demonstrated
that oncology providers are generally comfortable with sexual
minority patients, but less so with specific gender minorities such
as transgender patients. Additionally, these studies demonstrated
that knowledge about SGM-specific oncology healthcare needs is
limited, but oncologists expressed interest in receiving education
and training about such issues (Shetty et al., 2016; Tamargo et al.,
2017; Schabath et al., 2019; Sutter et al., 2020). Building on our
prior work that focused on oncologists at NCI-Designated Cancer
Centers, the current study was conducted among a more diverse
population of providers that included oncologists, nurses, and
physician assistants who are members of the ECOG-ACRIN
Cancer Research Group (merger of Eastern Cooperative Oncology
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Materials and methods
Study population and survey design
We administered a web-based survey to members of the
ECOG-ACRIN Cancer Research Group in late 2019. The validated
survey was developed from published surveys on the knowledge,
attitudes, and practice behaviors of clinicians regarding providing
cancer care to SGM individuals, and has been revised and utilized
by our group in other studies (Bonvicini and Perlin, 2003; Garcia,
2003; Kelley et al., 2008; Kitts, 2010; Reed et al., 2010; Abdessamad
et al., 2013; Lim et al., 2013; Schabath et al., 2019). The survey
included 19 demographic questions, 12 items on attitudes toward
treating SGM patients, seven SGM-related knowledge questions,
four practice-related questions focusing on intake forms, and four
open-ended questions. The open-ended questions were, “Please
describe any personal experiences treating LGBTQ patients that
you consider important or informative,” “Please explain any
reservations in treating the LGBTQ population,” “What
suggestions do you have for improving the cancer care of the
LGBTQ population?” and “Please provide any additional
comments.” We report here on the results of the openended questions.

Analysis
Inductive and deductive content analyses as well as the
constant comparison method were used to guide analysis (Elo and
Kyngäs, 2008; Constant Comparison, 2011). Two members of the
team conducted the coding and analysis process. First, using the
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survey questions, one team member performed open coding to
develop an initial codebook using the a priori themes from the
survey questions. Next, each team member separately attempted
to apply the a priori codes from the original list to 25 survey
responses with the additional goal of identifying any new or
emergent themes. Then the two coders met to compare their
coding and discuss emergent themes. The code list was then
revised, emergent themes were added to the list and applied again
to another 25 responses, and conflicts were resolved through
discussion. Once the two coders had reached an acceptable
interrater reliability rate (81%; McHugh, 2012), then each coder
read all 558 survey responses, and both team members
independently identified themes associated with each response.
Final differences in coding were resolved via discussion among
team members until consensuses were reached. Finally, the coders
reviewed all coding from each of the four questions and chose the
most commonly reported and unifying themes to highlight in
the manuscript.

TABLE 1 Characteristics of clinicians who responded to open-ended
question(s).

Characteristic
Age, mean (SD)

48.3 (12.1)

Gender, n (%)
Female

167 (73.2)

Male

48 (21.1)

Male-to-female transgender

1 (0.4)

Prefer not to answer

11 (4.8)

Did not answer

1 (0.4)

Sexual orientation, n (%)
Heterosexual

185 (81.1)

Bisexual

8 (3.5)

Gay

6 (2.6)

Lesbian

6 (2.6)

Other

2 (0.9)

Prefer not to answer

18 (7.9)

Did not answer

3 (1.3)

Race, n (%)
White/Caucasian

Results
Among the 490 healthcare providers who responded to the
survey, 228 (46.5%) provided responses to one or more openended questions, amounting to 558 total individual responses.
Among respondents who reported their demographic
information, the average age was 48.3 (SD 12.1), and most
identified as white (74.6%), non-Hispanic/Latino (89.0%),
heterosexual (81.1%), Christian (53.9%), and female (73.2%;
Table 1). Over one-third (37.3%) were registered nurses,
followed by 30.3% who were licensed medical doctors
specializing predominantly in hematology and/or oncology. The
majority of respondents (60.1%) reported seeing zero to 25
patients per week, and the greatest proportion (46.1%)
approximated that 1–5% of their patients in the last year had
identified as LGBTQ.
We identified multiple themes from the 558 responses. The
major themes we highlighted were lack of experience treating
SGM patients, challenges related to gender identification and
pronoun use, providers’ perceptions of SGM patient attitudes,
positive experiences with SGM populations, end-of-life issues
related to SGM oncologic care, specific clinical care scenarios
involving SGM populations, and the need for education and
training (Supplementary Table 1).

170 (74.6)

Multiracial

14 (6.1)

Black/African–American

12 (5.3)

Asian

9 (3.9)

American Indian/Alaska Native

1 (0.4)

Hawaiian/Pacific Islander

1 (0.4)

Other/not sure

1 (0.4)

Prefer not to answer

17 (7.5)

Did not answer

3 (1.3)

Ethnicity, n (%)
Not hispanic/Latino

203 (89.0)

Hispanic/Latino

7 (3.1)

Prefer not to answer

17 (7.5)

Did not answer

1 (0.4)

Religious identity, n (%)
Christian

123 (53.9)

Not religious

32 (14.0)

Atheist/agnostic

27 (11.8)

Jewish

6 (2.6)

Hindu

5 (2.2)

Muslim

4 (1.8)

Buddhist

1 (0.4)

Other

10 (4.4)

Prefer not to answer

18 (7.9)

Did not answer

2 (0.9)

Political leaning, n (%)

Lack of experience
Providers may feel uncomfortable when treating, or
be unprepared to treat, SGM patients because they have limited
experience with this patient population. Furthermore, even when
they do interact with SGM patients, they may not be aware of the
patients’ sexual orientations or gender identities. One provider
reported this experience precisely:

Frontiers in Psychology

Liberal

62 (27.2)

Somewhat Liberal

32 (14.0)

Centrist/moderate

25 (11.0)

Very liberal

24 (10.5)

Conservative

22 (9.6)

Somewhat conservative

18 (7.9)

Very conservative

3 (1.3)

Other

5 (2.2)
(Continued)
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TABLE 1 Continued

Pronouns and gender identification

Characteristic
Prefer not to answer
Did not answer

Many SGM individuals, particularly those who identify as
transgender, nonbinary, or genderqueer, use pronouns different
from those assigned at birth, including traditional pronouns such
as “he” and “she” or gender-inclusive pronouns such as “zie.” One
of the most prevalent themes that emerged was providers’
concerns about using the proper pronouns for SGM patients, or
clinical scenarios complicated by pronouns. Multiple providers
recounted experiences of improper pronoun use in the clinical
setting, as evidenced by the quote below where the patients should
have had “she/her” in the medical record:

36 (15.8)
1 (0.4)

Geographic region, n (%)
East North Central

50 (21.9)

Middle Atlantic

37 (16.2)

West North Central

33 (14.5)

South Atlantic

28 (12.3)

New England

24 (10.5)

Pacific

19 (8.3)

East South Central

14 (6.1)

West South Central

13 (5.7)

Mountain

8 (3.5)

Did not answer

2 (0.9)

“I treated a transgender woman and all the pronouns in the
notes were he/him.”

Practice settinga
Main campus of AMCb/Medical School

109 (47.8)

Community Hospital

59 (25.9)

NCORPc community site

43 (18.9)

Medical center not affiliated with medical school

21 (9.2)

Office-based

32 (14.0)

Satellite clinic of AMCb

12 (5.3)

NCORP minority/underserved site

9 (3.9)

c

VA or other government entity

1 (0.4)

Other

12 (5.3)

Clinicians also provided comments suggesting they had
trouble keeping track of pronouns in relation to sex assigned
at birth:
“We had a transgender [patient] who felt the MD was being
mean by referring to his birth gender but it was a factor in the
genetics of her disease.”
One provider relayed a similar experience and highlighted
weaknesses in the healthcare system that contribute to
the problem:

Licensurea
Registered Nurse (RN)

85 (37.3)

Doctor of Medicine (MD)

69 (30.3)

Doctor of Philosophy (PhD)

7 (3.1)

Nurse Practitioner (NP)

7 (3.1)

Doctor of Osteopathic Medicine (DO)

2 (0.9)

Physician Assistant (PA)

“… Also no obvious area in … patient’s EMR to identify their
gender identity/preferred (sic) pronouns. I would hope this
would be something that would be listed right next to
something as important as their DOB.”

1 (0.4)

Other

45 (19.7)

Prefer not to answer

17 (7.5)

Did not answer

22 (9.6)

Some providers focused not on pronouns directly, but rather
on institutional barriers related to gender identity, particularly
among transgender patients:

Able to give multiple answers.
Academic Medical Center.
c
National Cancer Institute Oncology Research Program.
a

“Screened a [transgender] patient for an oncology clinical
trial, neither the physicians at our hospital, nor sponsors
with the drug company, could say with conviction if
we should enroll the patient according to her presenting
gender identity or gender assigned at birth. Ultimately, the
patient declined being screened for the study because of the
hesitation regarding treatment. I believe we did the patient
a disservice.”

b

“I have no experience speaking with patients of the LGBTQ
community. If I did, it was not [to] my knowledge.”
Notably, many providers indicated limited exposure to
some SGM patient populations, particularly transgender
patients, but greater familiarity with others, such as gay and
lesbian patients:

Perceived patient attitudes

“I have had limited experience with transgender [patients],
I feel more comfortable with gay/lesbian individuals as I have
had more work/social experiences with them.”

When asked about reservations in treating SGM patients, a
minority of respondents made assumptions about SGM patients’
previous negative experiences with healthcare providers:

“Quite minimal. Live in a rural area. Only have had interaction
with gay/lesbian patients (that I am aware of)”

Frontiers in Psychology
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“Due to discrimination, the LGBTQ patients I have worked
with are very hostile at first expecting they are going to
be treated differently and judged.”

they are not pregnant and haven’t had sex with a male. But
I tell them [it’s] an institutional policy …”
Other respondents highlighted clinical scenarios in which
sexual and/or gender orientation were objectively and inextricably
linked to patient care:

Positive experiences
Although many providers focused on challenges they faced
with SGM patients, others recounted favorable encounters:

“I have seen a couple of patients that wish to convert from a
female chest to a male chest hoping that [bilateral]
mastectomies for high risk would achieve the desired
cosmetic appearance”

“I worked in an AIDS clinic for 16 years and had many
wonderful experiences with the LGTBQ population. They
taught me may things!”

Other respondents described situations in which it seemed
imperative to know a patient’s sex at birth:

“Treating LGBTQ patients can be very rewarding …”
“In radiation oncology practice, received a referral on a
gender-reassigned individual for squamous cell ‘cervical’
cancer. No mention in the [medical] record that this patient
was male at birth and ‘cervix’ was actually penile tissue
transplanted in gender-reassignment surgery. In calculating
drug dosing (e.g. carboplatin)[,] [estimated glomerular
filtration rate, a measure of kidney function] is different for
males/females. QTc [an interval on an electrocardiogram]
ranges are different for males/females. I believe it’s important
to know if the patient’s organs are male organs or
female organs.”

“Excellent experience with the LGBTQ community[.]”
“My experience with this patient [population has]
been positive.”

End-of-life care
Three respondents recounted their own experiences with
end-of-life care in SGM patients:
“I have a female patient with advanced lung cancer who has
adult children from a former male partner. She has a female
partner now that she’s been … with for 18 years. The patient has
estranged relationships with some of her adult children because
of this. It is important to understand the personal/social issues
our patients are going through in order to provide the best care.
At some point, this patient will encounter end-of-life issues, and
her family dynamics will be an issue and a worry for her.”

“Was surprised by my [patient’s] gender at the time of surgery
when a Foley [catheter] was being placed. This led to a
potential crisis of … [misidentification].”
Still others asked questions about SGM-specific clinical needs
in the oncology setting:
“I treat breast cancer patients and while I have not treated a
transgender patient, I would think that lowering a patient’s
estrogen levels to avoid cancer recurrence could negatively
impact a transgender patient’s quality of life. I would
be interested in knowing what other clinicians do in
this scenario.”

“Treating terminal cancer patients, it was important to know
about decision makers and ensure the patient has a
living will.”
“Have treated LGBTQ patients with AIDS/HIV and assisted
with End of Life Care. Majority of time [the patients were]
alone at the End of Life.”

“I work with survivorship and feel there should be a booklet
on sexual problems that they may face. For instance: Are there
issues with postmenopausal women and vaginal dryness
for lesbians?”

Clinical care

Education and training

While some providers had little to no experience with SGM
patients, others saw them regularly. Such providers reported
difficulty determining when to apply institutional sex-based
policies among SGM patients:

While a vast array of additional themes emerged, perhaps the
most unifying was the recognition that more education and training
for providers on SGM healthcare is needed. When asked, “What
suggestions do you have for improving the cancer care of the LGBTQ
population?,” 97 of 184 responses were related to this need:

“Sometimes we have a hard time convincing lesbian women
about getting a pre-study urine pregnancy test. They insist

Frontiers in Psychology
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Discussion

“I think that there should be mandatory training on different
things we should be aware of when interacting with the
LGBTQ population.”

Building on our prior work conducted among oncologists
at NCI-Designated Cancer Centers, the current study was
conducted among oncologists, nurses, and physician assistants
within the ECOG-ACRIN Cancer Research Group. As such,
the goal of this study was to identify the range of oncology
care providers’ experiences with, reservations toward, and
suggestions for improvement in SGM cancer care to generate
potential targets for intervention to improve care for this
underserved population. Almost half of the 490 respondents
provided at least one answer to an open-ended question, and
together these responses evoked several common themes.
Respondents reported largely positive or neutral experiences
with SGM patients, with very few outright negative attitudes
toward this population.
Many respondents described a lack of exposure to SGM
patients, most notably transgender patients; with this came
provider concerns about correct pronoun use among
transgender patients. A lack of experience with transgender
patients has been seen in our group’s previous studies; however,
this concern for pronoun use is more prominent in the current
study (Shetty et al., 2016; Schabath et al., 2019; Sutter et al.,
2020). This may reflect the growing cultural sensitivity
surrounding SGM-specific issues in society as a whole – i.e.,
providers were familiar enough with transgender issues that
many of them independently recognized the more nuanced
topic of pronouns as a challenge facing this population. This
awareness of pronouns as an issue in SGM health was also seen
in a recent survey of medical students, wherein most
participants believed incorrect pronoun use may lead to
patients’ nondisclosure of SGM status (Jamieson et al., 2020).
However, these same findings demonstrate there is still room to
grow in competence with respect to caring for SGM patients.
Other studies of healthcare providers and transgender patients
have confirmed these shortcomings and demonstrated that they
serve as barriers to care. For example, Sanchez et al. noted that the
most frequently reported barrier to care among male-to-female
transgender patients surveyed was access to a provider
knowledgeable about transgender health issues (32%), followed by
access to a transgender-friendly healthcare provider (30%;
Sanchez et al., 2009). A study of transgender youths and their
caregivers confirmed that inconsistent use of one’s chosen name
and/or pronouns was a major barrier to care (Gridley et al., 2016).
A recent survey of oncologists in the United Kingdom showed that
49% of surveyed providers never asked a patient’s gender identity,
64% never asked a patient’s pronouns, and 87% stated they always
or often assumed a patient was cisgender (Berner et al., 2020).
Among gay men and lesbian women, interactions with healthcare
providers who demonstrated fear of behaving incorrectly hindered
communication with providers (Röndahl et al., 2006); this
provider fear may apply to the use of gender pronouns as well.
In addition to these highly prevalent themes of lack of
experience and challenges with pronouns, smaller numbers of

“Education in all healthcare settings regardless if healthcare
setting is backed by a religious organization”
“Training and ensuring all providers and staff are aware of
appropriate interactions. We have had nurses who have
worked hard to ensure all staff address transgender patients
appropriately. Everyone should be responsive without a nurse
having to be the champion for the transgender patient any
more than they are champions for all patients.”
“Sensitivity training is a must”
“Educate providers on sensitivity to the topic. If they need
specifically different care, publish in [the National
Comprehensive Cancer Network] guidelines or update them.”
“As a part of the LGBT community myself, this survey is
making me aware of my own lack of knowledge regarding the
health disparities and challenges that the LGBT community
might face, so I would be really interested in seeing healthcare
providers educated on these issues.”

Building rapport
Many providers also highlighted ways they attempt to connect
and build rapport with their SGM patients. These efforts included
using inclusive language, disclosing their own identities as SGM
when applicable, and getting personally involved in the
SGM community:
“I am gay and I would think very inclusive. I use open
conversation (a/k/a do you live with a loved one?) … I recently
had a gay man, after I gently coaxed that he had a partner/
male, and then I shared that I had a husband …”
“I have many [LGBTQ] friends and have tried to be an active
part of the community”
“I am a Gay male physician and have significant
involvement in my community, medical center and medical
school in relation to LGBTQ issues, education
and awareness”
Few providers demonstrated negative attitudes toward this
population, exemplifying ways to not build rapport:
“I personally think it is wrong”
“Don’t be so sensitive, stop [having] a victim attitude”
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providers raised two unique considerations: perceived distrust of
providers among SGM patients and end-of-life care. Regarding
the former, providers’ perceptions of SGM patients’ hesitations is
not commonly surveyed, but anecdotal reports of hostility and
suspicion toward healthcare providers may be rooted in previous
negative experiences with healthcare providers. A series of studies
by Nadal et al. identified microaggressions that SGM people face,
such as use of heterosexist terminology and endorsement of
heteronormative culture, as well as common SGM responses to
these microaggressions including behavioral, cognitive, and/or
emotional reactions (Nadal et al., 2011a,b, 2016). Although these
studies were not exclusively conducted in the healthcare setting,
other studies have confirmed that SGM patients face similar
microaggressions from – in addition to overt discrimination by
– healthcare providers (Dean et al., 2016). Thus, we hypothesize
that suspicion toward healthcare providers is a product not
of sexual or gender orientation per se, but of previous
negative experiences.
With regard to end-of-life care, respondents noted
challenges related to advance directives, decision-making, and
family dynamics. Although the end of life can be physically,
emotionally, and ethically challenging regardless of a person’s
sexual or gender orientation, SGM patients face their own
unique concerns at this juncture (Sprik and Gentile, 2020).
The responses here highlight some of the nuances to end-oflife care in SGM patients. For example, they may face
homophobia from healthcare providers (Bristowe et al., 2016);
may avoid end-of-life healthcare altogether due to previous
discrimination by healthcare providers (Bristowe et al., 2018);
and often encounter legal and financial barriers related to lack
of relationship recognition (Bristowe et al., 2016, 2018; Sprik
and Gentile, 2020). End-of-life care is a fundamental
component of many cancer patients’ journeys. Therefore, to
more fully care for SGM patients at the end of life, oncology
providers must understand their SGM patients’ relationships
with their partners and families and any system barriers,
which requires patient-provider trust and rapport. In-depth
goals-of-care discussions, which may or may not include
concerns directly related to SGM status, must be an active
component of end-of-life care. Training in culturally
responsive care and cultural humility, involving components
of knowledge, self-reflection, and active listening, has been
proposed to reduce SGM health disparities at the end of life,
though proper care at this essential juncture will require
provider engagement and enthusiasm as well (Sprik and
Gentile, 2020).
A larger proportion of providers mentioned aspects of clinical
care specific to SGM populations that they found challenging,
ranging from screening guidelines to sexual health. The findings
from the current study confirm our previous findings of
oncologists at NCI-Designated Cancer Centers where providers
requested increased dissemination of guidelines for screening and
treatment of various conditions in this population (Sutter et al.,
2020). Furthermore, we previously demonstrated lack of
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knowledge of appropriate screening practices in SGM patients
(Tamargo et al., 2017; Schabath et al., 2019).
Largely in response to such limited knowledge in treating
SGM patients with cancer, the single most important theme that
emerged from the qualitative responses in the current study was
the need for increased provider education and training. Thus,
there is a pressing need for curriculum development to address
cancer disparities in SGM patients and to promote culturally
responsive care. Provider training programs have been developed
by the Fenway Institute and National LGBT Health Foundation,
but training specifically for oncology providers has been limited.
The Curriculum for Oncologists on LGBT populations to
Optimize Relevance and Skills (COLORS) training program was
developed for this purpose, and offers modules focused on SGM
basics, inclusive environments, initiating oncology care with SGM
patients, and issues in cancer survivorship among SGM patients
(Seay et al., 2020). Training programs like the online Educating
Nurses about Reproductive Issues in Cancer Healthcare
(ENRICH) effectively engage non-physician oncology care
providers as valuable team members and may improve the
healthcare experience of SGM populations (Quinn et al., 2019;
Sutter et al., 2020).
Some providers highlighted an additional need for
institutional and policy changes to further SGM oncologic
health. Multiple providers mentioned challenges in enrolling
transgender patients in clinical trials, citing lack of clarity
regarding whether transgender patients were eligible for studies
and regarding how to classify transgender patients in terms of
gender. Although to our knowledge there has not been research
further delineating or quantifying these limitations to clinical
trial enrollment, multiple studies have identified other
institutional barriers to SGM health. One major barrier is a lack
of concrete screening guidelines for SGM patients, especially
transgender patients, as most published guidelines are based on
cisgender patients (Haviland et al., 2020); furthermore, it may
be more difficult for transgender patients to get appropriate
screening tests approved if such screening tests are recommended
for the opposite gender (Agénor et al., 2015). Thus, in addition
to needing improved education and training for providers,
institutional policy changes are needed to provide better SGM
healthcare. Another institutional barrier is lack of collection of
sexual orientation and gender identity data (SOGI) in the
medical record (Institute of Medicine Committee on Lesbian G,
Bisexual, and Transgender Health Issues and Research Gaps and
Opportunities, 2011; Alexander et al., 2020); the Centers for
Medicare and Medicaid Services and the Department of Human
Services now require electronic health records to include
structured fields for SOGI data, but barriers to thorough and
consistent collection remain, and many prominent cancer
registries do not include SOGI data (Burkhalter et al., 2016).
Furthermore, while some institutions have non-discrimination
policies, it is often unclear who can access SOGI data or that a
patient has a right to verbally relay this information and not have
it in their medical records (Thompson, 2016; Brooks et al., 2018).
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Author contributions

A final theme highlighted in this study centered on providers’
efforts to build rapport with their SGM patients through both
their one-on-one interactions with patients and their involvement
in the SGM community. Encouragingly, these reported provider
behaviors reflect greater acceptance of SGM patients – this
increased acceptance is also supported by the many positive
experiences respondents recounted. These themes together
suggest provider desire and enthusiasm for improving one’s
ability to care appropriately for SGM oncologic patients. This
desire and enthusiasm may enhance the effects of knowledge and
training in culturally responsive care and significantly improve
the experience of SGM patients, as the success of such training
depends also on the providers undertaking it.
We acknowledge several limitations to the study, most
importantly the moderate response rate (46.5%) to qualitative
questions among survey respondents. Additionally, although
approximately 4.5% of the population identifies as LGBTQ, 8.7%
of respondents stated they were lesbian, gay, or bisexual, suggesting
that a disproportionate number of respondents identify as SGM
(Conron and Goldberg, 2020). This may contribute to nonresponse
bias, with those less familiar or less comfortable with SGM patient
populations or alternatively do not believe this is a significant care
delivery issue being less likely to respond. Clinicians more invested
in SGM health disparities and/or healthcare delivery, including
those who themselves identify as LGBTQ, may have been more
likely to complete the survey, particularly the optional qualitative
questions. Additionally, the large proportion of positive or neutral
to negative responses may reflect social desirability bias, in which
survey respondents answered questions in ways more likely to
be viewed favorably (Hebert et al., 1997).
Overall, the qualitative comments of this survey highlight
oncology care providers’ need for increased exposure to and
training on SGM cancer care and culturally responsive care. This
and our prior studies demonstrate that oncology care providers
are not only willing to engage in such training, but also
independently recognize this need. Furthermore, this training
should extend beyond physicians and include the broader
healthcare team to influence the most meaningful change.
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